West Pharmaceutical Services WST Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $542.7M+9.9% | $493.7M+0.4% | $491.7M+0.8% | $487.7M+4.4% | $467.2M-5.2% | ||
| $174.1M+3.3% | $168.6M+4.1% | $162M+1.9% | $159M+1.8% | $156.2M+2.9% | ||
| $29.1M+22.3% | $23.8M+11.2% | $21.4M+18.2% | $18.1M+20.7% | $15M-19.8% | ||
| $11.7M0.0% | $11.7M+19.4% | $9.8M-6.7% | $10.5M+50.0% | $7M-4.1% | ||
| —— | -$6.9M-172% | $9.53M-63.3% | $25.95M-38.8% | $42.38M-27.9% | ||
| —— | $62.8M+71.6% | $36.6M+252% | $10.4M+166% | -$15.8M+62.4% | ||
| —— | $17.9M+26.5% | $14.15M+36.1% | $10.4M+56.4% | $6.65M+129% | ||
| -$112M-3.6% | -$108.1M-287% | -$27.9M-19.7% | -$23.3M+57.1% | -$54.3M-140% | ||
| —— | -$9.7M-66.5% | -$5.83M-199% | -$1.95M-201% | $1.93M-66.8% | ||
| —— | $10.5M-6.5% | $11.23M-6.1% | $11.95M-5.7% | $12.68M-5.4% | ||
| $715.3M-5.2% | $754.8M+8.8% | $693.8M+2.5% | $676.7M+1.8% | $664.6M+1.7% | ||
| $257.3M-10.0% | $285.9M-9.2% | $314.7M-5.4% | $332.7M-7.0% | $357.7M-5.1% | ||
| -$257.3M+10.0% | -$285.9M+9.1% | -$314.6M+5.6% | -$333.4M+7.2% | -$359.4M+5.1% | ||
| $61.8M+1.0% | $61.2M+0.8% | $60.7M+1.0% | $60.1M+0.8% | $59.6M+0.8% | ||
| —— | —— | —— | $240.8M-43.7% | $427.4M-23.8% | ||
| $14.3M+26.5% | $11.3M+16.5% | $9.7M-16.4% | $11.6M-12.1% | $13.2M-48.2% | ||
| $1.2M+9.1% | $1.1M+22.2% | $900K0.0% | $900K-96.2% | $23.5M+0.4% | ||
| $2.8M0.0% | $2.8M0.0% | $2.8M+3.7% | $2.7M-3.6% | $2.8M-50.9% | ||
| -$346.8M-87.4% | -$185.1M+23.6% | -$242.3M+17.9% | -$295.2M+40.8% | -$498.6M+19.9% | ||
| —— | —— | —— | $15.4M+467% | -$4.2M+80.4% | ||
| $117.2M-61.8% | $306.7M+123% | $137.6M— | —— | —— | ||
| —— | $300K-14.3% | $350K-12.5% | $400K-11.1% | $450K-10.0% | ||
| —— | $125.2M+12.0% | $111.75M+13.7% | $98.3M+15.9% | $84.85M+18.8% | ||
| $2.5M-10.7% | $2.8M-9.7% | $3.1M-6.1% | $3.3M-8.3% | $3.6M0.0% | ||
| $11.7M0.0% | $11.7M+19.4% | $9.8M-6.7% | $10.5M+50.0% | $7M-4.1% | ||
| $174.1M+3.3% | $168.6M+4.1% | $162M+1.9% | $159M+1.8% | $156.2M+2.9% | ||
| —— | $10.5M-6.5% | $11.23M-6.1% | $11.95M-5.7% | $12.68M-5.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | -$9.7M-66.5% | -$5.83M-199% | -$1.95M-201% | $1.93M-66.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | $600K+1,300% | -$50K+92.9% | -$700K+48.1% | -$1.35M+32.5% | ||
| $1.2M+9.1% | $1.1M+22.2% | $900K0.0% | $900K-96.2% | $23.5M+0.4% | ||
| $7M+1.4% | $6.9M-1.4% | $7M-1.4% | $7.1M0.0% | $7.1M-1.4% | ||
| —— | —— | $2.5M+56.3% | $1.6M+100% | $800K— | ||
| —— | $125.2M+12.0% | $111.75M+13.7% | $98.3M+15.9% | $84.85M+18.8% | ||
| $458M-2.3% | $468.9M+23.7% | $379.1M+10.2% | $344M+12.1% | $306.9M+11.0% | ||
| $458M-2.3% | $468.9M+23.7% | $379.1M+10.2% | $344M+12.1% | $306.9M+11.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
